Astec LifeSciences launches Rs. 100 crore Adi Godrej Center for Chemical Research and Development
To enable company to be future-ready by tapping potential in CDMO space
To enable company to be future-ready by tapping potential in CDMO space
Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
The new sterile filling line meets cGMP aseptic filling regulatory requirements
New manufacturing facility dedicated to the production of active pharmaceutical ingredients (APIs) and high potency active pharmaceutical ingredients (HPAPIs)
The investment enhances Lonza’s capabilities and flexibility to support both clinical and commercial supply and will play a key role in meeting the growing market demand for bioconjugates
Subscribe To Our Newsletter & Stay Updated